Loading organization details...
Loading organization details...
Source: IRS Form 990 via ProPublica Nonprofit Explorer
Total Revenue
▼$8,056
Total Contributions
N/A
Total Expenses
▼$44.9K
Total Assets
$213.4K
Total Liabilities
▼$1,200
Net Assets
N/A
Officer Compensation
→N/A
Other Salaries
N/A
Investment Income
▼N/A
Fundraising
▼N/A
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
$2M
VA/DoD Award Count
1
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding
$22.9M
Awards Found
28
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | HEALTH CENTER PROGRAM | $7M | FY2015 | Aug 2015 – May 2026 |
| Department of Health and Human Services | HEALTH CENTER PROGRAM | $3.1M | FY2015 | Aug 2015 – May 2019 |
| Department of Justice | THE RECREATIONAL DRUG ENVIRONMENT IN THE UNITED STATES IS MORE DYNAMIC AND VOLATILE THAN EVER BEFORE, IN LARGE PART DUE TO THE DOMINANCE OF POTENT LEGACY SYNTHETIC DRUGS, EMERGENCE OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS), AND THE CONTINUED PROLIFERATION OF NEW ADULTERANTS INTO TRADITIONAL DRUG SUPPLIES. KEEPING PACE WITH NPS DRUGS AND DRUG TRENDS REMAINS ONE OF THE GREATEST TECHNICAL AND ANALYTICAL CHALLENGES FACING FORENSIC SCIENTISTS, AND ONE OF THE GREATEST PUBLIC HEALTH THREATS TO COMMUNITIES WHERE DRUG USE IS PREVALENT. ONE ASPECT OF NPS REMAINS CLEAR THESE DRUGS CONTINUE TO EMERGE AND PROLIFERATE THROUGHOUT NATIONAL DRUG MARKETS WITH VARYING WAVES OF POSITIVITY AND PREVALENCE. OUR MULTIDISCIPLINARY PROPOSAL IS DESIGNED TO LEVERAGE AND BUILD ON PRIOR NIJ-FUNDED RESEARCH IN NEW TECHNOLOGY, METHOD DEVELOPMENTS, VALIDATION, AND APPLICATION TO FACILITATE THE DELIVERY OF THE NOVEL PSYCHOACTIVE SUBSTANCE DISCOVERY, EDUCATION, AND REPORTING INSTITUTE (NPS DISCERN). OUR RESEARCH TEAM WILL RAPIDLY IDENTIFY EMERGING SUBSTANCES AND CHANGES TO DRUG MARKETS BY CHARACTERIZING NOVEL DRUGS IN DIVERSE AND HIGH-RISK POPULATIONS (E.G., MEDICOLEGAL DEATH INVESTIGATIONS, DRUG IMPAIRED DRIVING, CLINICAL INTOXICATIONS, WASTEWATER SURVEILLANCE, DRUG MATERIAL TESTING, ETC.). OUR GOAL IS TO RAPIDLY SHARE METHODS, ANALYTICAL DATA, TOXICOLOGICAL FINDINGS, METABOLISM RESEARCH, AND MORE WITH THE FORENSIC PRACTITIONER COMMUNITY AND BEYOND TO IMPROVE RATES OF DETECTION OF NEW AND EMERGING DRUGS. OUR PROPOSED PROJECT WILL ENSURE ACCURATE AND TIMELY REPORTING OF NPS, AID SCHEDULING AND CONTROL ACTIONS, SUPPORT HARM REDUCTION AND TREATMENT STRATEGIES, AND ASSIST WITH INTERDICTION AND DRUG TRAFFICKING INTELLIGENCE EFFORTS. SAMPLE SOURCES AND POPULATIONS WILL PRIMARILY INCLUDE FORENSIC TOXICOLOGY SPECIMENS, CLINICAL TOXICOLOGY SPECIMENS, AND DRUG MATERIAL SAMPLES THREE KEY ASPECTS TO ACCURATELY ASSESS THE DRUG MARKET AND FATAL VS. NON-FATAL OUTCOMES. THE MAIN OBJECTIVES OF THIS PROPOSAL ARE TO: 1) ESTABLISH AND FACILITATE THE OPERATION OF AN OPEN-ACCESS DRUG EARLY WARNING SYSTEM, 2) DEVELOP ANALYTICAL RESOURCES TO ASSIST LABORATORIES, 3) FACILITATE THE FORENSICALLY RELEVANT DRUG DATABASE AS A GO-TO RESOURCE FOR INFORMATION REGARDING NPS, AND 4) PROVIDE EDUCATION AND KNOWLEDGE TRANSFER REGARDING FINDINGS AND OUTCOMES. THIS APPROACH WILL STRENGTHEN THE FORENSIC SCIENCE COMMUNITY BY RELIEVING THE BURDEN ON PRACTICING LABORATORIES TO PERFORM IN-HOUSE SURVEILLANCE, MONITORING, RESEARCH, COMPLEX CONFIRMATIONS, AND NEW METHOD DEVELOPMENTS. LETTERS OF SUPPORT FROM FORENSIC TOXICOLOGISTS AND CHEMISTS, CRIME LABORATORY PERSONNEL, PUBLIC HEALTH AND SAFETY AGENCIES, CLINICAL PRACTITIONERS, AND STATE/FEDERAL PARTNERS ARE INCLUDED TO REINFORCE THE VALUE OF TIMELY DATA AND ACCURATE INFORMATION THAT CAN BE DISTRIBUTED ACROSS VARIOUS CHANNELS WITH INTEREST TO PUBLIC HEALTH AND SAFETY. CA/NCF | $2M | FY2025 | Jan 2025 – Dec 2027 |
| VA/DoDDepartment of Defense | VALIDATOIN OF A MASS SPECTROMETRY BASED SEROLOGICAL ASSAY | $2M | FY2015 | Sep 2015 – Jun 2021 |
| Department of Justice | ILLICIT AND RECREATIONAL DRUG USE IN THE UNITED STATES ARE MAJOR CONTRIBUTORS TO MORBIDITY AND MORTALITY, ESPECIALLY AMONG VULNERABLE POPULATIONS. WHILE LAW ENFORCEMENT AGENCIES AND THE CRIMINAL JUSTICE COMMUNITY CONTINUE TO COMBAT HARMS LINKED TO DRUG USE, CONTINUOUS CHALLENGING PHENOMENA REMAIN POSING FORENSIC AND LEGAL CONSEQUENCES. ONE ASPECT IS CERTAIN – DRUG TRENDS AND DRUG USE PATTERNS CONTINUE TO CHANGE AND EVOLVE WITH TIME AND GEOGRAPHICAL REGION, ESPECIALLY IN THE CONTEXT OF NEW AND EMERGING DRUG THREATS. NEW SYNTHETIC DRUGS, ALSO REFERRED TO AS NOVEL PSYCHOACTIVE SUBSTANCES (NPS), REPRESENT A GROWING SUB-CLASS OF CONCERN AS PHARMACOLOGICAL POTENCIES INCREASE AND NEW DRUGS INFILTRATE TRADITIONAL DRUG SUPPLIES. KEEPING PACE WITH THE MOST CURRENT DRUGS REMAINS ONE OF THE GREATEST TECHNICAL CHALLENGES FACING FORENSIC CHEMISTS AND TOXICOLOGISTS TODAY. THIS MULTIDISCIPLINARY PROPOSAL IS DESIGNED TO BUILD ON PRIOR NIJ-FUNDED RESEARCH IN METHOD DEVELOPMENT, VALIDATION, AND APPLICATION TO APPLY NOVEL TOOLS TO THE IDENTIFICATION OF EMERGING DRUGS, TO CHARACTERIZE THESE DRUGS IN FORENSIC TOXICOLOGICAL AND CHEMISTRY SAMPLES, AND TO SHARE METHODS, ANALYTICAL DATA, TOXICOLOGICAL DATA, AND MORE, WITH THE FORENSIC PRACTITIONER COMMUNITY. OUR LABORATORY WILL PARTNER WITH MEDICAL EXAMINERS, CORONERS, TOXICOLOGISTS, CHEMISTS, LAW ENFORCEMENT, PUBLIC HEALTH, AND VARIOUS FORENSIC LABORATORIES ACROSS THE UNITED STATES TO ACQUIRE AND ANALYZE AUTHENTIC TOXICOLOGY SAMPLES (E.G., BLOOD, URINE) AND DRUG MATERIALS (E.G., POWDER, PILL). LIQUID CHROMATOGRAPHY QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY (LC-QTOF-MS) AND LIQUID CHROMATOGRAPHY TANDEM QUADRUPOLE MASS SPECTROMETRY (LC-QQQ-MS) WILL PRIMARILY BE USED FOR COMPREHENSIVE DRUG TESTING. NPS IN THE DRUG SUPPLY WILL BE DISCOVERED THROUGH EXTENSIVE SURVEILLANCE INITIATIVES FOLLOWED BY DRUG MONITORING TO DETERMINE PREVALENCE, POSITIVITY, TRENDS, DRUG COMBINATIONS, AND OTHER CHARACTERISTICS. METABOLISM OF NEWLY DISCOVERED NPS WILL BE STUDIED TO ASSIST TOXICOLOGY INVESTIGATIONS. NEW CONFIRMATORY METHODS WILL BE RAPIDLY DEVELOPED FOR APPLICATION TO AUTHENTIC SAMPLES, GAINING DRUG CONCENTRATION DATA TO DEVELOP REFERENCE RANGES. ALL ACQUIRED DATA AND INFORMATION WILL BE PROCESSED INTO HIGH-IMPACT REPORTS TO SERVE AS BLUEPRINTS FOR SCIENTISTS, CLINICIANS, PRACTITIONERS, AND OTHER STAKEHOLDERS INTERESTED IN VARIOUS INFORMATION ABOUT NEWLY EMERGING DRUGS AND THEIR IMPACTS. A KEY COMPONENT OF THIS PROJECT IS THE EXTENSIVE DISSEMINATION OF DELIVERABLE TO THE FORENSIC SCIENCE, CRIMINAL JUSTICE, PUBLIC HEALTH, AND PUBLIC SAFETY COMMUNITIES. REPORTS AND PUBLICATION WILL BE MADE AVAILABLE OPEN-ACCESS TO FORENSIC SCIENCE AND CRIMINAL JUSTICE PARTNERS. OVERALL, THIS RESEARCH WILL FACILITATE AND ENSURE MORE ACCURATE AND TIMELY REPORTING OF NEW DRUGS, AID SCHEDULING AND CONTROL ACTIONS, AND ASSIST WITH INTERDICTION EFFORTS AND DRUG TRAFFICKING INTELLIGENCE. CA/NCF | $978.7K | FY2023 | Jan 2023 – Dec 2024 |
| Department of Justice | REAL-TIME SAMPLE-MINING AND DATA-MINING APPROACHES FOR THE DISCOVERY OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS) | $755.4K | FY2021 | Jan 2021 – Dec 2024 |
| Department of Health and Human Services | AMERICAN RESCUE PLAN ACT FUNDING FOR HEALTH CENTERS | $742K | FY2021 | Apr 2021 – Mar 2024 |
| Department of Housing and Urban Development | EDI SPECIAL PROJECTS | $588K | FY2009 | Oct 2008 – Aug 2009 |
| Department of Labor | YOUTH BUILD | $548.9K | FY2008 | Oct 2007 – Oct 2010 |
| Department of Health and Human Services | HEALTH CENTER CORONAVIRUS AID, RELIEF, AND ECONOMIC SECURITY (CARES) ACT FUNDING | $521.9K | FY2020 | Apr 2020 – Mar 2022 |
| Department of Justice | COMPARATIVE ASSESSMENT OF EMERGING TECHNOLOGIES FOR BODY FLUID IDENTIFICATION | $501.1K | FY2021 | Jan 2021 – Jun 2022 |
| Department of Justice | TOXICOLOGICAL TIME TRAVEL: RETROSPECTIVE DATAMINING OF ANALYTICAL TIME-OF-FLIGHT MASS SPECTROMETRY DATA FOR EVALUATING THE RISE AND FALL OF NOVEL OPIOID AND FENTANYL ANALOG USE IN THE UNITED STATES | $499K | FY2018 | Jan 2018 – Mar 2020 |
| Department of Justice | RETROSPECTIVE IDENTIFICATION OF SYNTHETIC CANNABINOIDS IN FORENSIC TOXICOLOGY CASEWORK USING ARCHIVED HIGH RESOLUTION MASS SPECTROMETRY DATA | $494.7K | FY2018 | Jan 2018 – Dec 2019 |
| Department of Justice | EVALUATION AND OPTIMIZATION OF DNA RECOVERY AND AMPLIFICATION FROM BULLET CARTRIDGE CASES | $494.6K | FY2016 | Jan 2016 – Dec 2018 |
| Department of Justice | ASSESSMENT OF THE CONTRIBUTION TO DRUG IMPAIRED DRIVING FROM EMERGING AND UNDERTESTED DRUGS | $478.8K | FY2021 | Jan 2021 – Dec 2022 |
| Department of Health and Human Services | HEALTH CENTER INFRASTRUCTURE SUPPORT | $468.3K | FY2021 | Sep 2021 – Sep 2025 |
| Department of Justice | IDENTIFICATION OF ANTICOAGULANT ADULTERANTS IN SEIZED MATERIAL AND BIOLOGICAL SAMPLES | $412.1K | FY2020 | Jan 2020 – Dec 2021 |
| Department of Justice | MONITORING CHANGES IN THE NOVEL PSYCHOACTIVE SUBSTANCE (NPS) MARKET THROUGH ENHANCED IDENTIFICATION OF EMERGING DRUGS AND THEIR METABOLITES IN BIOL | $378.2K | FY2016 | Jan 2016 – Mar 2018 |
| Department of Justice | DEVELOPMENT OF A COMPREHENSIVE WORKFLOW FOR POSTMORTEM INSULIN TESTING IN CASES OF SUSPECTED INSULIN HOMICIDE | $299.5K | FY2019 | Jan 2019 – Dec 2020 |
| Department of Justice | IDENTIFICATION AND PREVALENCE DETERMINATION OF NOVEL RECREATIONAL DRUGS AND DISCOVERY OF THEIR METABOLITES IN BLOOD, URINE AND ORAL FLUID | $225.6K | FY2014 | Oct 2013 – Sep 2015 |
| Department of Health and Human Services | FY 2020 EXPANDING CAPACITY FOR CORONAVIRUS TESTING (ECT) | $112.1K | FY2020 | May 2020 – Apr 2021 |
| Department of Health and Human Services | FY 2023 EXPANDING COVID-19 VACCINATION | $81.9K | FY2023 | Dec 2022 – Dec 2023 |
| Department of Health and Human Services | AFFORDABLE CARE ACT- HEALTH CENTER PLANNING GRANTS | $80K | FY2011 | Sep 2011 – Aug 2012 |
| Department of Health and Human Services | FY 2020 CORONAVIRUS SUPPLEMENTAL FUNDING FOR HEALTH CENTERS | $51.5K | FY2020 | Mar 2020 – Mar 2021 |
| Department of Health and Human Services | FY 2023 BRIDGE ACCESS PROGRAM | $12.3K | FY2023 | Sep 2023 – Dec 2024 |
| Department of State | FOR YOUNG PEOPLE TO EXPLORE AMERICAN CULTURE, BUSINESS, AND U.S.-UK SHARED VALUES THROUGH WORKSHOPS PROMOTING GREATER AWARENESS OF U.S. CULTURE. | $8,200 | FY2020 | Apr 2020 – Apr 2021 |
| Department of State | RECIPIENT WILL ORGANIZE A NUMBER OF CULTURAL AND ARTISTIC WORKSHOPS FOR AT LEAST 35 13-17 YEAR OLDS ON ENTREPRENEURSHIP. CYBERSECURITY AND TECHNOLOGY | $6,644 | FY2019 | Mar 2019 – Mar 2020 |
| Department of State | TO ORGANIZE A YOUTH COP26 SUMMIT TO INCREASE KNOWLEDGE OF THE CLIMATE CRISIS AND COP26. | $5,000 | FY2022 | Oct 2021 – Feb 2022 |
Department of Health and Human Services
$7M
HEALTH CENTER PROGRAM
Department of Health and Human Services
$3.1M
HEALTH CENTER PROGRAM
Department of Justice
$2M
THE RECREATIONAL DRUG ENVIRONMENT IN THE UNITED STATES IS MORE DYNAMIC AND VOLATILE THAN EVER BEFORE, IN LARGE PART DUE TO THE DOMINANCE OF POTENT LEGACY SYNTHETIC DRUGS, EMERGENCE OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS), AND THE CONTINUED PROLIFERATION OF NEW ADULTERANTS INTO TRADITIONAL DRUG SUPPLIES. KEEPING PACE WITH NPS DRUGS AND DRUG TRENDS REMAINS ONE OF THE GREATEST TECHNICAL AND ANALYTICAL CHALLENGES FACING FORENSIC SCIENTISTS, AND ONE OF THE GREATEST PUBLIC HEALTH THREATS TO COMMUNITIES WHERE DRUG USE IS PREVALENT. ONE ASPECT OF NPS REMAINS CLEAR THESE DRUGS CONTINUE TO EMERGE AND PROLIFERATE THROUGHOUT NATIONAL DRUG MARKETS WITH VARYING WAVES OF POSITIVITY AND PREVALENCE. OUR MULTIDISCIPLINARY PROPOSAL IS DESIGNED TO LEVERAGE AND BUILD ON PRIOR NIJ-FUNDED RESEARCH IN NEW TECHNOLOGY, METHOD DEVELOPMENTS, VALIDATION, AND APPLICATION TO FACILITATE THE DELIVERY OF THE NOVEL PSYCHOACTIVE SUBSTANCE DISCOVERY, EDUCATION, AND REPORTING INSTITUTE (NPS DISCERN). OUR RESEARCH TEAM WILL RAPIDLY IDENTIFY EMERGING SUBSTANCES AND CHANGES TO DRUG MARKETS BY CHARACTERIZING NOVEL DRUGS IN DIVERSE AND HIGH-RISK POPULATIONS (E.G., MEDICOLEGAL DEATH INVESTIGATIONS, DRUG IMPAIRED DRIVING, CLINICAL INTOXICATIONS, WASTEWATER SURVEILLANCE, DRUG MATERIAL TESTING, ETC.). OUR GOAL IS TO RAPIDLY SHARE METHODS, ANALYTICAL DATA, TOXICOLOGICAL FINDINGS, METABOLISM RESEARCH, AND MORE WITH THE FORENSIC PRACTITIONER COMMUNITY AND BEYOND TO IMPROVE RATES OF DETECTION OF NEW AND EMERGING DRUGS. OUR PROPOSED PROJECT WILL ENSURE ACCURATE AND TIMELY REPORTING OF NPS, AID SCHEDULING AND CONTROL ACTIONS, SUPPORT HARM REDUCTION AND TREATMENT STRATEGIES, AND ASSIST WITH INTERDICTION AND DRUG TRAFFICKING INTELLIGENCE EFFORTS. SAMPLE SOURCES AND POPULATIONS WILL PRIMARILY INCLUDE FORENSIC TOXICOLOGY SPECIMENS, CLINICAL TOXICOLOGY SPECIMENS, AND DRUG MATERIAL SAMPLES THREE KEY ASPECTS TO ACCURATELY ASSESS THE DRUG MARKET AND FATAL VS. NON-FATAL OUTCOMES. THE MAIN OBJECTIVES OF THIS PROPOSAL ARE TO: 1) ESTABLISH AND FACILITATE THE OPERATION OF AN OPEN-ACCESS DRUG EARLY WARNING SYSTEM, 2) DEVELOP ANALYTICAL RESOURCES TO ASSIST LABORATORIES, 3) FACILITATE THE FORENSICALLY RELEVANT DRUG DATABASE AS A GO-TO RESOURCE FOR INFORMATION REGARDING NPS, AND 4) PROVIDE EDUCATION AND KNOWLEDGE TRANSFER REGARDING FINDINGS AND OUTCOMES. THIS APPROACH WILL STRENGTHEN THE FORENSIC SCIENCE COMMUNITY BY RELIEVING THE BURDEN ON PRACTICING LABORATORIES TO PERFORM IN-HOUSE SURVEILLANCE, MONITORING, RESEARCH, COMPLEX CONFIRMATIONS, AND NEW METHOD DEVELOPMENTS. LETTERS OF SUPPORT FROM FORENSIC TOXICOLOGISTS AND CHEMISTS, CRIME LABORATORY PERSONNEL, PUBLIC HEALTH AND SAFETY AGENCIES, CLINICAL PRACTITIONERS, AND STATE/FEDERAL PARTNERS ARE INCLUDED TO REINFORCE THE VALUE OF TIMELY DATA AND ACCURATE INFORMATION THAT CAN BE DISTRIBUTED ACROSS VARIOUS CHANNELS WITH INTEREST TO PUBLIC HEALTH AND SAFETY. CA/NCF
Department of Defense
$2M
VALIDATOIN OF A MASS SPECTROMETRY BASED SEROLOGICAL ASSAY
Department of Justice
$978.7K
ILLICIT AND RECREATIONAL DRUG USE IN THE UNITED STATES ARE MAJOR CONTRIBUTORS TO MORBIDITY AND MORTALITY, ESPECIALLY AMONG VULNERABLE POPULATIONS. WHILE LAW ENFORCEMENT AGENCIES AND THE CRIMINAL JUSTICE COMMUNITY CONTINUE TO COMBAT HARMS LINKED TO DRUG USE, CONTINUOUS CHALLENGING PHENOMENA REMAIN POSING FORENSIC AND LEGAL CONSEQUENCES. ONE ASPECT IS CERTAIN – DRUG TRENDS AND DRUG USE PATTERNS CONTINUE TO CHANGE AND EVOLVE WITH TIME AND GEOGRAPHICAL REGION, ESPECIALLY IN THE CONTEXT OF NEW AND EMERGING DRUG THREATS. NEW SYNTHETIC DRUGS, ALSO REFERRED TO AS NOVEL PSYCHOACTIVE SUBSTANCES (NPS), REPRESENT A GROWING SUB-CLASS OF CONCERN AS PHARMACOLOGICAL POTENCIES INCREASE AND NEW DRUGS INFILTRATE TRADITIONAL DRUG SUPPLIES. KEEPING PACE WITH THE MOST CURRENT DRUGS REMAINS ONE OF THE GREATEST TECHNICAL CHALLENGES FACING FORENSIC CHEMISTS AND TOXICOLOGISTS TODAY. THIS MULTIDISCIPLINARY PROPOSAL IS DESIGNED TO BUILD ON PRIOR NIJ-FUNDED RESEARCH IN METHOD DEVELOPMENT, VALIDATION, AND APPLICATION TO APPLY NOVEL TOOLS TO THE IDENTIFICATION OF EMERGING DRUGS, TO CHARACTERIZE THESE DRUGS IN FORENSIC TOXICOLOGICAL AND CHEMISTRY SAMPLES, AND TO SHARE METHODS, ANALYTICAL DATA, TOXICOLOGICAL DATA, AND MORE, WITH THE FORENSIC PRACTITIONER COMMUNITY. OUR LABORATORY WILL PARTNER WITH MEDICAL EXAMINERS, CORONERS, TOXICOLOGISTS, CHEMISTS, LAW ENFORCEMENT, PUBLIC HEALTH, AND VARIOUS FORENSIC LABORATORIES ACROSS THE UNITED STATES TO ACQUIRE AND ANALYZE AUTHENTIC TOXICOLOGY SAMPLES (E.G., BLOOD, URINE) AND DRUG MATERIALS (E.G., POWDER, PILL). LIQUID CHROMATOGRAPHY QUADRUPOLE TIME-OF-FLIGHT MASS SPECTROMETRY (LC-QTOF-MS) AND LIQUID CHROMATOGRAPHY TANDEM QUADRUPOLE MASS SPECTROMETRY (LC-QQQ-MS) WILL PRIMARILY BE USED FOR COMPREHENSIVE DRUG TESTING. NPS IN THE DRUG SUPPLY WILL BE DISCOVERED THROUGH EXTENSIVE SURVEILLANCE INITIATIVES FOLLOWED BY DRUG MONITORING TO DETERMINE PREVALENCE, POSITIVITY, TRENDS, DRUG COMBINATIONS, AND OTHER CHARACTERISTICS. METABOLISM OF NEWLY DISCOVERED NPS WILL BE STUDIED TO ASSIST TOXICOLOGY INVESTIGATIONS. NEW CONFIRMATORY METHODS WILL BE RAPIDLY DEVELOPED FOR APPLICATION TO AUTHENTIC SAMPLES, GAINING DRUG CONCENTRATION DATA TO DEVELOP REFERENCE RANGES. ALL ACQUIRED DATA AND INFORMATION WILL BE PROCESSED INTO HIGH-IMPACT REPORTS TO SERVE AS BLUEPRINTS FOR SCIENTISTS, CLINICIANS, PRACTITIONERS, AND OTHER STAKEHOLDERS INTERESTED IN VARIOUS INFORMATION ABOUT NEWLY EMERGING DRUGS AND THEIR IMPACTS. A KEY COMPONENT OF THIS PROJECT IS THE EXTENSIVE DISSEMINATION OF DELIVERABLE TO THE FORENSIC SCIENCE, CRIMINAL JUSTICE, PUBLIC HEALTH, AND PUBLIC SAFETY COMMUNITIES. REPORTS AND PUBLICATION WILL BE MADE AVAILABLE OPEN-ACCESS TO FORENSIC SCIENCE AND CRIMINAL JUSTICE PARTNERS. OVERALL, THIS RESEARCH WILL FACILITATE AND ENSURE MORE ACCURATE AND TIMELY REPORTING OF NEW DRUGS, AID SCHEDULING AND CONTROL ACTIONS, AND ASSIST WITH INTERDICTION EFFORTS AND DRUG TRAFFICKING INTELLIGENCE. CA/NCF
Department of Justice
$755.4K
REAL-TIME SAMPLE-MINING AND DATA-MINING APPROACHES FOR THE DISCOVERY OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS)
Department of Health and Human Services
$742K
AMERICAN RESCUE PLAN ACT FUNDING FOR HEALTH CENTERS
Department of Housing and Urban Development
$588K
EDI SPECIAL PROJECTS
Department of Labor
$548.9K
YOUTH BUILD
Department of Health and Human Services
$521.9K
HEALTH CENTER CORONAVIRUS AID, RELIEF, AND ECONOMIC SECURITY (CARES) ACT FUNDING
Department of Justice
$501.1K
COMPARATIVE ASSESSMENT OF EMERGING TECHNOLOGIES FOR BODY FLUID IDENTIFICATION
Department of Justice
$499K
TOXICOLOGICAL TIME TRAVEL: RETROSPECTIVE DATAMINING OF ANALYTICAL TIME-OF-FLIGHT MASS SPECTROMETRY DATA FOR EVALUATING THE RISE AND FALL OF NOVEL OPIOID AND FENTANYL ANALOG USE IN THE UNITED STATES
Department of Justice
$494.7K
RETROSPECTIVE IDENTIFICATION OF SYNTHETIC CANNABINOIDS IN FORENSIC TOXICOLOGY CASEWORK USING ARCHIVED HIGH RESOLUTION MASS SPECTROMETRY DATA
Department of Justice
$494.6K
EVALUATION AND OPTIMIZATION OF DNA RECOVERY AND AMPLIFICATION FROM BULLET CARTRIDGE CASES
Department of Justice
$478.8K
ASSESSMENT OF THE CONTRIBUTION TO DRUG IMPAIRED DRIVING FROM EMERGING AND UNDERTESTED DRUGS
Department of Health and Human Services
$468.3K
HEALTH CENTER INFRASTRUCTURE SUPPORT
Department of Justice
$412.1K
IDENTIFICATION OF ANTICOAGULANT ADULTERANTS IN SEIZED MATERIAL AND BIOLOGICAL SAMPLES
Department of Justice
$378.2K
MONITORING CHANGES IN THE NOVEL PSYCHOACTIVE SUBSTANCE (NPS) MARKET THROUGH ENHANCED IDENTIFICATION OF EMERGING DRUGS AND THEIR METABOLITES IN BIOL
Department of Justice
$299.5K
DEVELOPMENT OF A COMPREHENSIVE WORKFLOW FOR POSTMORTEM INSULIN TESTING IN CASES OF SUSPECTED INSULIN HOMICIDE
Department of Justice
$225.6K
IDENTIFICATION AND PREVALENCE DETERMINATION OF NOVEL RECREATIONAL DRUGS AND DISCOVERY OF THEIR METABOLITES IN BLOOD, URINE AND ORAL FLUID
Department of Health and Human Services
$112.1K
FY 2020 EXPANDING CAPACITY FOR CORONAVIRUS TESTING (ECT)
Department of Health and Human Services
$81.9K
FY 2023 EXPANDING COVID-19 VACCINATION
Department of Health and Human Services
$80K
AFFORDABLE CARE ACT- HEALTH CENTER PLANNING GRANTS
Department of Health and Human Services
$51.5K
FY 2020 CORONAVIRUS SUPPLEMENTAL FUNDING FOR HEALTH CENTERS
Department of Health and Human Services
$12.3K
FY 2023 BRIDGE ACCESS PROGRAM
Department of State
$8,200
FOR YOUNG PEOPLE TO EXPLORE AMERICAN CULTURE, BUSINESS, AND U.S.-UK SHARED VALUES THROUGH WORKSHOPS PROMOTING GREATER AWARENESS OF U.S. CULTURE.
Department of State
$6,644
RECIPIENT WILL ORGANIZE A NUMBER OF CULTURAL AND ARTISTIC WORKSHOPS FOR AT LEAST 35 13-17 YEAR OLDS ON ENTREPRENEURSHIP. CYBERSECURITY AND TECHNOLOGY
Department of State
$5,000
TO ORGANIZE A YOUTH COP26 SUMMIT TO INCREASE KNOWLEDGE OF THE CLIMATE CRISIS AND COP26.
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Source: IRS e-Filed Form 990
No officer or director compensation data available for this organization.
This data is sourced from IRS Form 990, Part VII. It may not be available if the organization files Form 990-N (e-Postcard) or has not yet been enriched.
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023 | $8,056 | — | $44.9K | $213.4K | — |
| 2022 | $20.4K | — | $47.4K | $215.9K | — |
| 2021 | $144K | $95.8K | $36.1K | $283.5K | $283.5K |
| 2020 | $70.7K | — | $36.2K | $213.3K | — |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990-EZ | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990-EZ | DataIRS e-File | PDF not yet published by IRSView Filing → |
| 2022 | 990-EZ | DataIRS e-File |
Financial data: IRS Form 990 via ProPublica Nonprofit Explorer (Tax Year 2023)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File · ProPublica Nonprofit Explorer
Tax-deductibility: IRS Publication 78
| 2019 | $18.6K | — | $38.6K | $203.2K | — |
| 2018 | $111.1K | $99.2K | $33.9K | $187.7K | $187.7K |
| 2017 | $84.8K | — | $61.6K | $125.7K | — |
| 2016 | $46.7K | — | $22.6K | $95.4K | — |
| 2015 | $43.7K | — | $26.7K | $65.9K | — |
| 2014 | $35.6K | — | $12.3K | $51.2K | — |
| 2013 | $21.6K | — | $17K | $24.9K | — |
| 2012 | $8,407 | — | $36.6K | $23.5K | — |
| 2011 | $19K | — | $62.4K | $55K | — |
| 2021 | 990 | Data | PDF not yet published by IRS |
| 2020 | 990-EZ | Data | PDF not yet published by IRS |
| 2019 | 990-EZ | Data |
| 2018 | 990 | Data |
| 2017 | 990-EZ | Data |
| 2016 | 990-EZ | Data |
| 2015 | 990-EZ | Data |
| 2014 | 990-EZ | Data |
| 2013 | 990-EZ | Data |
| 2012 | 990-EZ | Data |
| 2011 | 990-EZ | Data |
| 2010 | 990 | — |
| 2009 | 990-EZ | — |
| 2008 | 990-EZ | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990-EZ | — |